Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L O'Connor

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Clinical Anesthesia|January 1, 1994
Cardiopulmonary arrest in the pregnant patient: a report of a successful resuscitationR L O'Connor, F B Sevarino
Clinical Orthopaedics and Related Research|June 1, 1982
Arthroscopic treatment of postoperative knee fibroarthrosisN F Sprague, R L O'Connor, J M Fox
Diabetes, Obesity & Metabolism|July 17, 2015
GSK2374697, a long duration glucagon-like peptide-1 (GLP-1) receptor agonist, reduces postprandial circulating endogenous total GLP-1 and peptide YY in healthy subjectsJ Lin, R J Hodge, R L O'Connor-Semmes, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 19, 2016
A Systems Model for Ursodeoxycholic Acid Metabolism in Healthy and Patients With Primary Biliary CirrhosisP Zuo, R L Dobbins, R L O'Connor-Semmes, et al.
Journal of Pharmaceutical Sciences|September 2, 1998
Stereoselective pharmacokinetics of chlorpheniramine and the effect of ranitidineK M Koch, R L O'Connor-Semmes, I M Davis, et al.
Clinical Pharmacology and Therapeutics|August 15, 2001
Effect of ranitidine on the pharmacokinetics of triazolam and alpha-hydroxytriazolam in both young (19-60 years) and older (61-78 years) peopleR L O'Connor-Semmes, K Kersey, D H Williams, et al.
Pharmaceutical Research|January 19, 1999
Use of the InteliSite capsule to study ranitidine absorption from various sites within the human intestinal tractY K Pithavala, W D Heizer, A F Parr, et al.
Clinical Pharmacology and Therapeutics|September 20, 2014
GSK2374697, a novel albumin-binding domain antibody (AlbudAb), extends systemic exposure of exendin-4: first study in humans--PK/PD and safetyR L O'Connor-Semmes, J Lin, R J Hodge, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Clinical Anesthesia|January 1, 1994
Cardiopulmonary arrest in the pregnant patient: a report of a successful resuscitationR L O'Connor, F B Sevarino
Clinical Orthopaedics and Related Research|June 1, 1982
Arthroscopic treatment of postoperative knee fibroarthrosisN F Sprague, R L O'Connor, J M Fox
Diabetes, Obesity & Metabolism|July 17, 2015
GSK2374697, a long duration glucagon-like peptide-1 (GLP-1) receptor agonist, reduces postprandial circulating endogenous total GLP-1 and peptide YY in healthy subjectsJ Lin, R J Hodge, R L O'Connor-Semmes, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 19, 2016
A Systems Model for Ursodeoxycholic Acid Metabolism in Healthy and Patients With Primary Biliary CirrhosisP Zuo, R L Dobbins, R L O'Connor-Semmes, et al.
Journal of Pharmaceutical Sciences|September 2, 1998
Stereoselective pharmacokinetics of chlorpheniramine and the effect of ranitidineK M Koch, R L O'Connor-Semmes, I M Davis, et al.
Clinical Pharmacology and Therapeutics|August 15, 2001
Effect of ranitidine on the pharmacokinetics of triazolam and alpha-hydroxytriazolam in both young (19-60 years) and older (61-78 years) peopleR L O'Connor-Semmes, K Kersey, D H Williams, et al.
Pharmaceutical Research|January 19, 1999
Use of the InteliSite capsule to study ranitidine absorption from various sites within the human intestinal tractY K Pithavala, W D Heizer, A F Parr, et al.
Clinical Pharmacology and Therapeutics|September 20, 2014
GSK2374697, a novel albumin-binding domain antibody (AlbudAb), extends systemic exposure of exendin-4: first study in humans--PK/PD and safetyR L O'Connor-Semmes, J Lin, R J Hodge, et al.
Pageof 1